Trials / Withdrawn
WithdrawnNCT03235492
Salivary Glycated Albumin
Clinical Study of Salivary Glycated Albumin
- Status
- Withdrawn
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 0 (actual)
- Sponsor
- University of Maryland, Baltimore · Academic / Other
- Sex
- All
- Age
- 18 Years – 80 Years
- Healthy volunteers
- Accepted
Summary
(1) to determine whether the ratio of glycated albumin and total albumin in saliva is equivalent to blood and (2) to investigate whether the non-invasive SmartAlbu portable salivary sensor is as accurate as standard tests that measure glycosylated hemoglobin (HbA1c).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DEVICE | SmartAlbu | Plan: 1. Consent an individual 2. Measure and record temperature, blood pressure, heart rate, height and weight 3. Obtain two samples of saliva for the SmartAlbu portable salivary sensor 4. Take a venous blood sample for HbA1c and 5. Glycated albumin 6. Obtain blood sample from a finger stick for point of care HbA1c device |
Timeline
- Start date
- 2017-08-24
- Primary completion
- 2023-12-05
- Completion
- 2023-12-05
- First posted
- 2017-08-01
- Last updated
- 2023-12-20
Locations
1 site across 1 country: United States
Source: ClinicalTrials.gov record NCT03235492. Inclusion in this directory is not an endorsement.